Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Frankfurt
06.06.25 | 08:05
1,160 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,1001,16017:19
1,1001,14017:22

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.04.Dividendenbekanntmachungen (28.04.2025)4.650 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AEON THANA SINSAP THAILAND PCL NVDR  TH0664010R11  2,95 THB  0,0774 EUR  BANCO DI DESIO E DELLA BRIANZA SPA  IT0001041000 - 0,4566 EUR  BRADESPAR...
► Artikel lesen
24.04.CMS (00867): FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION-
24.04.CMS (00867): ANNOUNCEMENT ON VOTING RESULTS OF ANNUAL GENERAL MEETING HELD ON 24 APRIL 2025-
22.04.CMS (00867): PROPOSED SPIN-OFF AND SEPARATE LISTING OF DERMAVON HOLDINGS LIMITED ON THE MAIN BOARD OF THE STOCK EXCHANGE OF HONG KONG LIMITED2
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
17.04.CMS (00867): PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION1
02.04.CMS (00867): FORM OF PROXY-
02.04.CMS (00867): NOTICE OF ANNUAL GENERAL MEETING-
02.04.CMS (00867): PROPOSALS FOR (1) RE-ELECTION OF THE RETIRING DIRECTORS (2) DECLARATION OF FINAL DIVIDEND (3) GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE ...-
02.04.CMS (00867): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024-
02.04.CMS (00867): ANNUAL REPORT 2024-
21.03.China Medical System Holdings Ltd. (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum277SHENZHEN, CHINA, March 21, 2025 (GLOBE NEWSWIRE) -- On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of...
► Artikel lesen
17.03.CMS (00867): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20248
17.03.CMS (00867): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION ...-
12.03.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR INNOVATIVE DRUG CARDIAC MYOSIN INHIBITOR CMS-D003-
05.03.CMS (00867): NOTICE OF BOARD MEETING-
14.02.China Medical System Holdings Ltd. (867.HK) is Included in the S&P Global Sustainability Yearbook 20255
24.01.China Medical System Holdings Ltd. (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10191SHENZHEN, CHINA, Jan. 24, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January...
► Artikel lesen
24.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A COLLABORATION AGREEMENT FOR CLASS 1 INNOVATIVE DRUG MG-K10 HUMANIZED MONOCLONAL ANTIBODY ...1
08.01.China Medical System Holdings Ltd. (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type136SHENZHEN, CHINA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January...
► Artikel lesen
08.01.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING A LICENSE, COLLABORATION AND DISTRIBUTION AGREEMENT OF IMPROVED NEW DRUG ZUNVEYL FOR THE ...-
Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1